Primary nervous-system lymphoma
- 1 June 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (6) , 354-365
- https://doi.org/10.1016/s1470-2045(00)00390-9
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphomaCancer, 2000
- VH Gene Sequences From Primary Central Nervous System Lymphomas Indicate Derivation From Highly Mutated Germinal Center B Cells With Ongoing Mutational ActivityBlood, 1999
- Primary central nervous system lymphoma: age and performance status are more important than treatment modalityInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Frequent In activation of CDKN2A and Rare Mutation of TP53 in PCNSLBrain Pathology, 1998
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.Journal of Clinical Oncology, 1991
- Increasing incidence of primary brain lymphoma in the USCancer, 1988
- Primary central nervous system lymphomaJournal of Neurosurgery, 1988
- RETICULUM CELL SARCOMA OF THE BRAINArchives of Neurology & Psychiatry, 1943
- INTRACRANIAL SARCOMATOUS TUMORS OF LEPTOMENINGEAL ORIGINArchives of Surgery, 1929